Xiamen AmonMed Biotechnology Co.
Latest round
- Series A
Last raised
- Aug 2018
Total raised
- Undisclosed
Investors
- 1
About Xiamen AmonMed Biotechnology Co.
, Ltd. operates as a high-tech enterprise, specializing in the development, production and sales of nano-fluorescence immunoassay analyzers and supporting kits, and also providing third-party medical testing services. In 2019, the company has obtained ISO 13485:2016 registration certification and in 2021 its product COVID-19 Antigen Schnelltest Kit certificated by BfArM Germany. The company has gained 12 patents in medical area. And there are 38 in vitro diagnostic reagents in the company, and 34 products of the company passed the EU CE certification. The company's products can be categorized into three different categories which are POCT instrument, fluorescence immunization and colloidal gold. Products within incudes AFS-1000 and AFS-2000A dry fluorescence immunoassay analyzers, COVID-19 Neutralizing Antibody Test Kit, COVID-19 Antigen Rapid Test Kit, COVID-19 IgM/IgG Test Kit and COVID-19/ Influenza A/ Influenza B Virus Antigen Assay Kit.
Who invested in Xiamen AmonMed Biotechnology Co.
1 investor across 1 round
See all investors in Xiamen AmonMed Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 1, 2018
Amount
Undisclosed
Investors
Questions about Xiamen AmonMed Biotechnology Co.
Who invested in Xiamen AmonMed Biotechnology Co.?
Xiamen AmonMed Biotechnology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xiamen AmonMed Biotechnology Co. raised?
Xiamen AmonMed Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xiamen AmonMed Biotechnology Co. last raise money?
Xiamen AmonMed Biotechnology Co.'s most recent round on record is a Series A, in Aug 2018.
What does Xiamen AmonMed Biotechnology Co. do?
Xiamen AmonMed Biotechnology Co. is a biotechnology company.
Where is Xiamen AmonMed Biotechnology Co. headquartered?
Xiamen AmonMed Biotechnology Co. is headquartered in Xiamen, China.
Which VCs invest in companies like Xiamen AmonMed Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Xiamen AmonMed Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Xiamen AmonMed Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.